[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334762-105":59,"doc-detail-334762-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","adherence-to-treatment-and-follow-up-of-precancerous-cervical-lesions-in-ethiopia-research-study-clinical-follow-up-and-adherence","Adherence to Treatment and Follow-Up of Precancerous Cervical Lesions in Ethiopia - Research Study - Clinical Follow-Up and Adherence","","In Ethiopia, cervical cancer incidence and mortality remain high, and screening services are being expanded. The World Health Organization recommends immediate treatment after a positive VIA result, followed by rescreening after one year because precancerous lesions may recur or persist despite therapy. This retrospective study reviewed screening logbooks from 14 Addis Ababa and Oromia facilities and analyzed questionnaire phone interviews with 741 VIA-positive women to assess adherence determinants.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/adherence-to-treatment-and-follow-up-of-precancerous-cervical-lesions-in-ethiopia-research-study-clinical-follow-up-and-adherence/334762/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/adherence-to-treatment-and-follow-up-of-precancerous-cervical-lesions-in-ethiopia-research-study-clinical-follow-up-and-adherence/334762.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is follow-up rescreening important after a positive VIA result in Ethiopia?","Question",{"text":113,"@type":114},"The study highlights that precancerous lesions can reoccur or become residential despite treatment. The WHO recommendation is to treat immediately and rescreen after 1 year to detect changes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What data sources and methods were used to evaluate adherence?",{"text":118,"@type":114},"Screening logbooks from 2017–2020 in 14 health facilities were reviewed to identify 741 women with VIA-positive results. Those women completed a questionnaire-based phone interview, and results were analyzed with descriptive methods and two generalized linear models.",{"name":120,"@type":111,"acceptedAnswer":121},"Which factors were found to influence adherence to follow-up?",{"text":122,"@type":114},"Educational status, age over 40, missing or incorrect follow-up appointments, health-facility related barriers, and the use of reminders were identified as important drivers of follow-up adherence.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334762,1790769023,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Adherence to Treatment and Follow-Up of Precancerous Cervical Lesions in Ethiopia  \nClara Yolanda Stroetmann1,, Muluken Gizaw1,2,3, Rahel Alemayehu2,  \nAbigiya Wondimagegnehu1,2,3,, Friedemann Rabe1, Pablo Santos1, Bariki Mchome4, Blandina Theophil Mmbaga5, Adamu Addissie1,2,3, Eva Johanna Kantelhardt*, 1,6,  \n1Global Health Working Group, Institute for Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany  \n2Department of Preventive Medicine, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia 3 NCD Working Group, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia  \n4Kilimanjaro Christian Medical Centre, Moshi, Tanzania  \n5Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre and Kilimanjaro Christian Medical University College, Moshi, Tanzania  \n6Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany  \n* Corresponding author: Eva J. Kantelhardt, MD, Global Health Working Group, Institute for Medical Epidemiology, Biometrics and Informatics, Martin-LutherUniversity Halle-Wittenberg, Magdeburger Straße 8, 06112 Halle (Saale), Germany. Email: [eva.kantelhardt@uk-halle.de](eva.kantelhardt@uk-halle.de)  \nAbstract  \nBackground: In Ethiopia, both incidence and mortality of cervical cancer are relatively high. Screening services, which were implemented during the past few years, are currently being expanded. The World Health Organization recommends patients with a positive VIA (visual inspection with acetic acid) result should immediately receive treatment followed by rescreening after 1 year as precancerous lesions can reoccur or become residential despite treatment.  \nMaterials and Methods: Screening logbooks dating between 2017 and 2020 were retrospectively reviewed in 14 health facilities of Addis Ababa and Oromia region. Data for 741 women with a VIA-positive result were extracted and those women were asked to participate in a questionnaire-based phone interview to gain insights about adherence to treatment and follow-up. Data were analyzed using descriptive methods and then fitted into 2 generalized linear models to test variables for an influence on adherence to follow up.  \nResults: Around 13 800 women had received a VIA screening, of which approximately 820 (5 .9%) were VIA positive. While over 90% of women with a positive screen received treatment, only about half of the treated patients returned for a follow-up examination. After treatment, 31 women had a VIA-positive re-screen. We found that educational status, age over 40, no/incorrect follow-up appointment, health facility-related barriers, and use of reminders are important drivers of adherence to follow up.  \nConclusion: Our results revealed that adherence to treatment after VIA positive screening is relatively high whereas adherence to follow up recommendations still needs improvement. Reminders like appointment cards and phone calls can effectively reduce the loss of follow-up. Key words: cervical cancer screening; precancerous lesions; cryotherapy; follow-up; adherence; recurrence.  \nImplications for Practice  \nThis study may contribute to the development of evidence-based guidelines for the appropriate follow-up of women with abnormal cervical cancer screening results. This study emphasizes the importance of appropriate follow-up of women with abnormal cervical cancer screening results and the adherence to those. Findings from the study may have implications for health policy decisions, guideline development and resource allocation. It can inform policymakers about the necessary infrastructure, training, and equipment needed for effective follow-up after cervical cancer screening. Additionally, the study results can help to improve patient education and counseling practices and can therefore alleviate anxiety, improve patient satisfaction, and foster informed decision-making.  \nIntroduction  \nCervical c","cbCaiiMiyNHbbzK2","https://ap.wps.com/l/cbCaiiMiyNHbbzK2","pdf",595731,"English","# Abstract\n## Background\n## Materials and Methods\n## Results\n## Conclusion\n# Implications for Practice\n# Introduction","[{\"question\":\"Why is follow-up rescreening important after a positive VIA result in Ethiopia?\",\"answer\":\"The study highlights that precancerous lesions can reoccur or become residential despite treatment. The WHO recommendation is to treat immediately and rescreen after 1 year to detect changes.\"},{\"question\":\"What data sources and methods were used to evaluate adherence?\",\"answer\":\"Screening logbooks from 2017–2020 in 14 health facilities were reviewed to identify 741 women with VIA-positive results. Those women completed a questionnaire-based phone interview, and results were analyzed with descriptive methods and two generalized linear models.\"},{\"question\":\"Which factors were found to influence adherence to follow-up?\",\"answer\":\"Educational status, age over 40, missing or incorrect follow-up appointments, health-facility related barriers, and the use of reminders were identified as important drivers of follow-up adherence.\"}]","Adherence to Treatment and Follow-Up of Precancerous Cervical Lesions in Ethiopia - Research Study - Clinical Follow-Up and Adherence | PDF",1790008261,25]